OncogenicPIK3CAmutations in lobular breast cancer progression

Increased signalling of EGFR and IGF1R and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas

(2012) A Gallardo et al.   BRITISH JOURNAL OF CANCER

Outcome of special types of luminal breast cancer

(2011) M. Colleoni et al.   ANNALS OF ONCOLOGY

PIK3CA mutations rarely demonstrate genotypic intratumoral heterogeneity and are selected for in breast cancer progression

(2011) Kevin Kalinsky et al.   BREAST CANCER RESEARCH AND TREATMENT

Mutational characterization of individual breast tumors: TP53 and PI3K pathway genes are frequently and distinctively mutated in different subtypes

(2011) Sandrine Boyault et al.   BREAST CANCER RESEARCH AND TREATMENT

Oncogenic PIK3CA mutations in colorectal cancers and polyps

(2011) Vicki L.J. Whitehall et al.   INTERNATIONAL JOURNAL OF CANCER

PI3K Inhibitors for Cancer Treatment: Five Years of Preclinical and Clinical Research after BEZ235

(2011) S.-M. Maira   MOLECULAR CANCER THERAPEUTICS

Locoregional treatment of primary breast cancer

(2010) Manfred Kaufmann et al.   CANCER

PIK3CA Mutations in In situ and Invasive Breast Carcinomas

(2010) A. Miron et al.   CANCER RESEARCH

PIK3CA Mutations May Be Discordant between Primary and Corresponding Metastatic Disease in Breast Cancer

(2010) J. Dupont Jensen et al.   CLINICAL CANCER RESEARCH

Predictive Biomarkers of Sensitivity to the Phosphatidylinositol 3' Kinase Inhibitor GDC-0941 in Breast Cancer Preclinical Models

(2010) C. O'Brien et al.   CLINICAL CANCER RESEARCH

Alterations in p53, BRCA1, ATM, PIK3CA, and HER2 genes and their effect in modifying clinicopathological characteristics and overall survival of Bulgarian patients with breast cancer

(2010) Stefan S. Bozhanov et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Lobular neoplasia: morphology, biological potential and management in core biopsies

(2010) Frances P O'Malley   MODERN PATHOLOGY

Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma

(2009) Jennifer Dunlap et al.   BREAST CANCER RESEARCH AND TREATMENT

High Incidence of Protein-Truncating TP53 Mutations in BRCA1-Related Breast Cancer

(2009) H. Holstege et al.   CANCER RESEARCH

PIK3CA Mutation Associates with Improved Outcome in Breast Cancer

(2009) K. Kalinsky et al.   CLINICAL CANCER RESEARCH

PIK3CA in Breast Carcinoma

(2009) Angela Michelucci et al.   DIAGNOSTIC MOLECULAR PATHOLOGY

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

(2009) Maggie C. U. Cheang et al.   JNCI-Journal of the National Cancer Institute

Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

(2009) Sohrab P. Shah et al.   NATURE

Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells

(2009) Hui-Fang Li et al.   Radiation Oncology

Aberrant Expression of E-cadherin in Lobular Carcinomas of the Breast

(2008) Leonard Da Silva et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer

(2008) K. Stemke-Hale et al.   CANCER RESEARCH

Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

(2008) M. C.U. Cheang et al.   CLINICAL CANCER RESEARCH

Immunohistochemical assessment of protein phosphorylation state: the dream and the reality

(2008) James W. Mandell   HISTOCHEMISTRY AND CELL BIOLOGY

Refinement of breast cancer classification by molecular characterization of histological special types

(2008) B Weigelt et al.   JOURNAL OF PATHOLOGY

Comprehensive genetic and functional characterization of IPH-926: a novelCDH1-null tumour cell line from human lobular breast cancer

(2008) Matthias Christgen et al.   JOURNAL OF PATHOLOGY

Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles

(2008) F Bertucci et al.   ONCOGENE

Helical domain and kinase domain mutations in p110  of phosphatidylinositol 3-kinase induce gain of function by different mechanisms

(2008) L. Zhao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Invasive lobular carcinoma of the breast: Response to hormonal therapy and outcomes

(2007) Emad A. Rakha et al.   EUROPEAN JOURNAL OF CANCER